logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Investor relations & media
  • SV
  • |
  • EN

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-01-30
Stockholm, Sweden, January 30, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Olof Sandén, board member and […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-01-24
  Stockholm, Sweden, January 24, 2024; Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 23 January 2024, regarding the final results of […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2024-12-16
Stockholm, Sweden, December 16, 2024; Inify Laboratories AB (publ.) announces that the below primary insider was allocated new shares at the Offer Price in the Private Placement as further specified […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2023-07-05
Stockholm, Sweden, July 5, 2023; Inify Laboratories AB (publ.) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: Monsun […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2022-08-19
Stockholm, Sweden, August 19, 2022 – Inify Laboratories AB (“Inify”) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: […]
Read More
  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calender

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    Twitter

© Inify® Laboratories